Publication | Open Access
High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
10
Citations
32
References
2016
Year
Increasing the dose of bevacizumab in refractory PED may be a possible treatment option.
| Year | Citations | |
|---|---|---|
Page 1
Page 1